Markets

Emcore and Valeant are this weeks Blowouts

A person taking notes from their tablet
Credit: Shutterstock photo

Brian Bolan is back with another edition of Bolan's Blowouts. This time we are taking a look at Valeant Pharma (VRX) and why it has been a Zacks Rank #5 (Strong Sell) for some time. Brian points to falling earnings estimates and then highlights who has been blowing out of the stock. Seems that Pershing Square has moved to sell more than 3M shares of this stock so this is only a partial blow out of a position that was more than 18M shares at one point.

Next is the stock that has seen a blowout earnings performance. Brian highlights Emcore (EMKR) which is up about 44% since the report. The key to the report was the higher guidance for revenue and Brian has a special chart just to show how revenue expectations have trended of late.

The Best & Worst of Zacks

Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +26% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 11X worse than the market. See these critical buys and sells free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

EMCORE CORP (EMKR): Free Stock Analysis Report

VALEANT PHARMA (VRX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EMKR

Other Topics

Stocks

Latest Markets Videos